Buckingham Strategic Partners Pacira Bio Sciences, Inc. Transaction History

Buckingham Strategic Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $159,885 - $195,210	-4,500 Reduced 31.25%	9,900 $404,000
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $148,253 - $223,020	-3,882 Reduced 21.23%	14,400 $555,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $207,317 - $238,268	4,046 Added 28.42%	18,282 $972,000
Q2 2022 Aug 12, 2022	SELL	$51.49 - $81.64 $51,541 - $81,721	-1,001 Reduced 6.57%	14,236 $830,000
Q1 2022 May 10, 2022	BUY	$60.03 - $76.49 $914,677 - $1.17 Million	15,237 New	15,237 $1.16 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

Stay updated on Buckingham Strategic Partners with notifications on news.